All Stories

  1. Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma
  2. Surgical Apgar Score Predicts an Increased Risk of Major Complications and Death after Renal Mass Excision
  3. Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques
  4. Retrospective Comparison of Cardiovascular Risk in Preselected Patients Undergoing Kidney Cancer Surgery: Reflection of Reality or Simply What We Want to Hear?
  5. Temporal Trends and Factors Associated with Systemic Therapy after Cytoreductive Nephrectomy: An Analysis of the National Cancer Database
  6. A Review of Interventional Clinical Trials in Renal Cell Carcinoma: A Status Report From the ClinicalTrials.gov WebSite
  7. Focal Therapy for Treatment of the Small Renal Mass: Dealer's Choice or a Therapeutic Gamble?
  8. Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity
  9. Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy
  10. Renal Pelvic Anatomy Is Associated with Incidence, Grade, and Need for Intervention for Urine Leak Following Partial Nephrectomy
  11. Reply
  12. Standardized Reporting of Resection Technique During Nephron-sparing Surgery: The Surface–Intermediate–Base Margin Score
  13. Is Extended Pharmacologic Venous Thromboembolism Prophylaxis Uniformly Safe After Radical Cystectomy?
  14. Care Transitions between Hospitals are Associated with Treatment Delay for Patients with Muscle Invasive Bladder Cancer
  15. Patients with anatomically “simple” renal masses are more likely to be placed on active surveillance than those with anatomically “complex” lesions
  16. European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media
  17. Coupling of Prostate and Thyroid Cancer Diagnoses in the United States
  18. Growth Kinetics and Short-Term Outcomes of cT1b and cT2 Renal Masses under Active Surveillance
  19. T1a Patients with Metastatic Renal Cell Cancer at Diagnosis Markedly Differ from Patients who Present with Localized Malignant Small Renal Mass (SRM)
  20. Is radical nephrectomy a legitimate therapeutic option in patients with renal masses amenable to nephron‐sparing surgery?
  21. Internal Validation of the Renal Pelvic Score: A Novel Marker of Renal Pelvic Anatomy That Predicts Urine Leak After Partial Nephrectomy
  22. Anatomic Complexity Quantitated by Nephrometry Score Is Associated With Prolonged Warm Ischemia Time During Robotic Partial Nephrectomy
  23. Variation in performance of candidate surgical quality measures for muscle‐invasive bladder cancer by hospital type
  24. Social Media Offers Unprecedented Opportunities for Vibrant Exchange of Professional Ideas Across Continents
  25. The rise and fall of prostate brachytherapy: Use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base
  26. Nephron‐sparing management vs radical nephroureterectomy for low‐ or moderate‐grade, low‐stage upper tract urothelial carcinoma
  27. MP65-19 PERFORMANCE OF PRIMARY RADICAL CYSTECTOMY AND RISK OF PATHOLOGIC UPSTAGING IN PATIENTS WITH STAGE I HIGH GRADE UROTHELIAL CARCINOMA OF THE BLADDER: A NATIONAL CANCER DATABASE ANALYSIS
  28. PD17-04 EXPERIENCE WITH ACTIVE SURVEILLANCE (AS) IN PATIENTS WITH RENAL MASS >4CM: ASSESSMENT OF GROWTH KINETICS AND OUTCOMES
  29. PD17-05 TUMOR ANATOMIC COMPLEXITY PREDICTS GROWTH KINETICS OF RENAL MASSES UNDER ACTIVE SURVEILLANCE
  30. MP30-19 LYMPHOPENIA IS AN INDEPENDENT PREDICTOR OF INFERIOR SURVIVAL IN PAPILLARY RENAL CELL CARCINOMA.
  31. MP59-07 PATIENTS WITH ANATOMICALLY “SIMPLE” RENAL MASSES ARE MORE LIKELY TO BE PLACED ON ACTIVE SURVEILLANCE THAN THOSE WITH ANATOMICALLY “COMPLEX” LESIONS
  32. MP2-04 EVALUATION OF THE ACS NSQIP SURGICAL RISK CALCULATOR IN PATIENTS UNDERGOING RADICAL CYSTECTOMY
  33. MP22-13 HOW SAFE IS EXTENDED PHARMACOLOGICAL VENOUS THROMBOEMBOLISM PROPHYLAXIS (EPVTEP) FOR PATIENT UNDERGOING RADICAL CYSTECTOMY?
  34. MP59-05 VALIDATION OF THE RENAL PELVIC SCORE: A NOVEL MARKER OF RENAL PELVIC ANATOMY THAT PREDICTS URINE LEAK FOLLOWING PARTIAL NEPHRECTOMY
  35. MP29-04 GAIN OF CHROMOSOME 8Q IS ASSOCIATED WITH INFERIOR SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA
  36. Assessing the Burden of Complications After Surgery for Clinically Localized Kidney Cancer by Age and Comorbidity Status
  37. MP40-06 MOST CYTOGENETICALLY PROVEN RENAL ONCOCYTOMAS AND CHROMOPHOBE CARCINOMAS CAN BE DIFFERENTIATED BY ROUTINE H&E AND CYTOKERATIN 7 STAINS ALONE
  38. MP40-17 THE METASTATIC POTENTIAL OF CHROMOPHOBE RCC IS DEPENDENT ON TUMOR SIZE: RESULTS FROM THE SEER DATABASE.
  39. Utilization of Brachytherapy for the Treatment of Localized Prostate Cancer in the National Cancer Database
  40. Coexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal Biopsy
  41. Splenogonadal Fusion: A Rare Etiology of Solid Testicular Mass
  42. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy
  43. The Publication Ranking Score for pediatric urology: Quantifying thought leadership within the subspecialty
  44. Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009
  45. Piperlongumine inhibits NF‐κB activity and attenuates aggressive growth characteristics of prostate cancer cells
  46. Partial Versus Radical Nephrectomy: Balancing Nephrons and Perioperative Risk
  47. Thermal ablation of the small renal mass: Case selection using the R.E.N.A.L.-Nephrometry Score
  48. Familiarity and Self-Reported Compliance with American Urological Association Best Practice Recommendations for Use of Thromboembolic Prophylaxis among American Urological Association Members
  49. Nutritional deficiency is associated with early mortality in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy
  50. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: A SEER database analysis
  51. Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non‐urological cancer care
  52. Differential Use of Partial Nephrectomy for Intermediate and High Complexity Tumors May Explain Variability in Reported Utilization Rates
  53. 1790 RENAL PELVIC ANATOMY IS ASSOCIATED WITH URINE LEAK FOLLOWING OPEN PARTIAL NEPHRECTOMY
  54. 1791 ASSESSING THE BURDEN OF COMPLICATIONS FOLLOWING RENAL SURGERY IN ELDERLY AND COMORBID PATIENTS
  55. 73 PATIENT COMORBIDITY STRATIFIED BY CHARLSON INDEX IS PREDICTIVE OF MEDICAL COMPLICATIONS FOLLOWING PARTIAL NEPHRECTOMY
  56. 420 DOES ADHERENCE TO CANDIDATE QUALITY MEASURES FOR MUSCLE INVASIVE BLADDER CANCER VARY BY HOSPITAL TYPE?
  57. Zinc and zinc transporters in prostate carcinogenesis
  58. Clinical Characteristics Associated With Treatment Type for Localized Renal Tumors: Implications for Practice Pattern Assessment
  59. Objectifying Complexity of Kidney Cancers: Relationships of Tumor Anatomy and Outcomes
  60. Pathological Concordance and Surgical Outcomes of Sporadic Synchronous Unilateral Multifocal Renal Masses Treated with Partial Nephrectomy
  61. Does Partial Nephrectomy Result in a Durable Overall Survival Benefit in the Medicare Population?
  62. Meaningful Comparison of Robotics Versus Laparoscopy for Nephron-sparing Surgery: No Contest or No Dice?
  63. Competing Risks of Death in Patients with Localized Renal Cell Carcinoma: A Comorbidity Based Model
  64. The Effect of 5-Aminolevulinic Acid and Its Derivatives on Protoporphyrin IX Accumulation and Apoptotic Cell Death in Castrate-resistant Prostate Cancer Cells
  65. Economic Burden of Repeat Renal Surgery on Solitary Kidney—Do the Ends Justify the Means? A Cost Analysis
  66. Enhancing Renal Tumors in Patients with Prior Normal Abdominal Imaging: Further Insight into the Natural History of Renal Cell Carcinoma
  67. RENAL Nephrometry Scoring System: The Radiologist’s Perspective
  68. Prostate Bed Motion During Intensity-Modulated Radiotherapy Treatment
  69. Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy
  70. Active Surveillance of the Small Renal Mass
  71. Trends in Regionalization of Adrenalectomy to Higher Volume Surgical Centers
  72. Assessing Performance Trends in Laparoscopic Nephrectomy and Nephron-sparing Surgery for Localized Renal Tumors
  73. Reply to Elias S. Hyams, Jeffrey K. Mullins, and Mohamad E. Allaf’s Letter to the Editor re: Alexander Kutikov, Boris Rozenfeld, Brian L. Egleston, et al. Academic Ranking Score: A Publication-Based Reproducible Metric of Thought Leadership in Urology....
  74. Perioperative Outcomes of Robotic and Open Partial Nephrectomy for Moderately and Highly Complex Renal Lesions
  75. Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells
  76. Biochemical and clinical experience with real-time intraoperatively planned permanent prostate brachytherapy
  77. The Role of Minimally Invasive Surgery in Multifocal Renal Cell Carcinoma
  78. Should Partial Nephrectomy Be Offered to All Patients Whenever Technically Feasible?
  79. Assessing the management of localized kidney cancer
  80. Academic Ranking Score: A Publication-Based Reproducible Metric of Thought Leadership in Urology
  81. Clinical Stage T1 Micropapillary Urothelial Carcinoma Presenting With Metastasis to the Pancreas
  82. Adrenocortical Carcinoma Masquerading as a Benign Adenoma on Computed Tomography Washout Study
  83. Partial nephrectomy for renal masses ≥7 cm: technical, oncological and functional outcomes
  84. Pathophysiology, Evaluation, and Medical Management of Adrenal Disorders
  85. Intensely Positron Emission Tomography-avid Benign Adrenal Adenoma
  86. Young age under 60years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer
  87. Surgical Approaches to Early Stage Kidney Cancer
  88. Utility of the R.E.N.A.L. Nephrometry Scoring System in Objectifying Treatment Decision-making of the Enhancing Renal Mass
  89. Objective Measures of Renal Mass Anatomic Complexity Predict Rates of Major Complications Following Partial Nephrectomy
  90. Interleukin-6: A Potential Biomarker of Resistance to Multitargeted Receptor Tyrosine Kinase Inhibitors in Castration-resistant Prostate Cancer
  91. Trends in regionalization of adrenalectomy to higher volume surgical centers
  92. How Hugh Hampton Young's Treatment of President Woodrow Wilson's Urinary Retention and Urosepsis Affected the Resolution of World War I
  93. Effects of Increased Cross-Sectional Imaging on the Diagnosis and Prognosis of Adrenocortical Carcinoma: Analysis of the National Cancer Database
  94. Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score
  95. Co‐administration of piperine and docetaxel results in improved anti‐tumor efficacy via inhibition of CYP3A4 activity
  96. Small renal masses progressing to metastases under active surveillance
  97. Delayed proximal ureteric stricture formation after complex partial nephrectomy
  98. Reply
  99. Prevalence of Baseline Chronic Kidney Disease in Patients Presenting With Solid Renal Tumors
  100. 55 AN INNOVATIVE WEB TOOL FOR OBJECTIFYING CRITICAL DECISION-MAKING IN PATIENTS WITH UROLOGIC CANCERS
  101. 442 REGIONALIZATION OF RADICAL CYSTECTOMY: TRENDS BY HOSPITAL VOLUME 1996–2009 USING STATE DISCHARGE DATA
  102. 408 INTERLEUKIN-6: A POTENTIAL BIOMARKER OF RESISTANCE TO MULTITARGETED RECEPTOR TYROSINE KINASE INHIBITORS IN CASTRATION-RESISTANT PROSTATE CANCER
  103. 22 INCIDENTAL SCREENING FOR ADRENOCORTICAL CARCINOMA (ACC): LESSONS FROM OVER 20 YEARS OF DATA FROM THE NATIONAL CANCER DATA BASE (NCDB)
  104. 1663 CHARACTERISTICS OF SMALL RENAL MASSES PROGRESSING TO METASTASES WHILE UNDER OBSERVATION: A POOLED ANALYSIS
  105. 1666 5 AND 10 YEAR CANCER SPECIFIC RISK OF DEATH FROM SPORADIC TYPE I (LOW GRADE) PAPILLARY RCC: A SEER ANALYSIS (1973–2007)
  106. 1659 QUANTIFICATION OF COMPETING RISKS OF DEATH IN PATIENTS WITH LOCALIZED RENAL CELL CARCINOMA (RCC): A COMPREHENSIVE NOMOGRAM INCORPORATING CO-MORBIDITIES
  107. Routine Adrenalectomy Is Unnecessary During Surgery for Large and/or Upper Pole Renal Tumors When the Adrenal Gland Is Radiographically Normal
  108. Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference?
  109. Docetaxel‐mediated apoptosis in myeloid progenitor TF‐1 cells is mitigated by zinc: Potential implication for prostate cancer therapy
  110. The Gatekeeper Disparity—Why Do Some Medical Schools Send More Medical Students Into Urology?
  111. Baseline Renal Function Status Limits Patient Eligibility to Receive Perioperative Chemotherapy for Invasive Bladder Cancer and Is Minimally Affected by Radical Cystectomy
  112. Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy
  113. Percutaneous vs surgical cryoablation of the small renal mass: is efficacy compromised?
  114. Impact of clinicopathological variables on mTOR Pathway activation in primary renal cell carcinoma (RCC) and matched metastases
  115. Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-κB-independent, proteasome-mediated mechanism
  116. Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy
  117. Robot-assisted Partial Nephrectomy: A Large Single-institutional Experience
  118. 26 ROUTINE ADRENALECTOMY IS UNNECESSARY DURING SURGERY FOR RENAL CELL CARCINOMA (RCC) - EVEN FOR LARGE AND/OR UPPER POLE TUMORS
  119. 2014 ULTRASOUND-GUIDED IMPLANTATION OF ELECTROMAGNETIC TRANSPONDERS INTO THE PROSTATE BED FOR LOCALIZATION AND TRACKING DURING INTENSITY MODULATED RADIATION THERAPY FOLLOWING RADICAL PROSTATECTOMY
  120. Reply
  121. Renal Masses Herniating Into the Hilum: Technical Considerations of the “Ball-valve Phenomenon” During Nephron-sparing Surgery
  122. The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth
  123. Management of Small Renal Masses
  124. The Impact of Residency Match Information Disseminated by a Third-Party Website
  125. PERCUTANEOUS VERSUS SURGICAL CRYOABLATION OF THE SMALL RENAL MASS (SRM): IS EFFICACY COMPROMISED?
  126. THE FOX CHASE R.E.N.A.L. NEPHROMETRY SCORE (R.E.N.A.L.-NS): A COMPREHESIVE STANDARDIZED SCORING SYSTEM FOR ASSESSING RENAL TUMOR SIZE, LOCATION, AND DEPTH
  127. MTOR PATHWAY ACTIVATION IN PRIMARY RENAL CELL CARCINOMA (RCC) AND MATCHED METASTASES
  128. PATIENTS WITH MEDICARE AS THE PRIMARY PAYER ARE LESS LIKELY TO UNDERGO NEPHRON SPARING SURGERY (NSS) FOR RENAL CELL CARCINOMA (RCC) THAN THEIR PRIVATELY INSURED COUNTERPARTS
  129. RAPID DISEASE PROGRESSION IS THE PRIMARY REASON PATIENTS FAIL TO RECEIVE SYSTEMIC THERAPY FOLLOWING CYTOREDUCTIVE NEPHRECTOMY (CN)
  130. Focal therapy for kidney cancer: a systematic review
  131. Testicular Compartment Syndrome: A New Approach to Conceptualizing and Managing Testicular Torsion
  132. Enucleation of renal cell carcinoma with ablation of the tumour base
  133. A case of synchronous bilateral testicular seminoma
  134. Communication Between the Ureter and an Aortic Aneurysm Sac After an Abdominal Aortic Aneurysm Repair
  135. Erratum: Modern management of pheochromocytoma
  136. Modern management of pheochromocytoma
  137. Laparoscopic and Robotic Complex Upper-Tract Reconstruction in Children with a Duplex Collecting System
  138. Should renal and bladder function be our compass for management of vesicoureteral reflux?
  139. Disorders of the Adrenal Gland
  140. Initial Experience With Laparoscopic Transvesical Ureteral Reimplantation at the Children’s Hospital of Philadelphia
  141. Robot Assisted Pyeloplasty in the Infant—Lessons Learned
  142. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging
  143. Clinical Approach to the Prostate: An Update
  144. Laparoscopic Pyeloplasty in the Infant Younger Than 6 Months—Is it Technically Possible?
  145. Synthesis, Characterization, and Cytotoxicity of a Series of Estrogen-Tethered Platinum(IV) Complexes
  146. Methyl B12Models Containing Unsubstituted Imidazole As an Axial Ligand Investigated by Structural and NMR Spectroscopic Methods. Evidence that μ-Imidazolato-Bridged Dimers Are Formed by Base Addition to Some Analogues with Macrocyclic Equato...